Inventiva S.A.
IVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001756594
No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $319.5M in total; no superinvestor holds it.
Other share classesIVEVF
Q3 2025 vs. Q2 2025
How the institutions holding Inventiva S.A. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 12 | 15 | +3 |
| Shares | 4.93M | 5.11M | +178.6K (+3.6%) |
| Value | $15.7M | $29.4M | +$13.7M (+87.7%) |
New holders (5)
Institutions that held Inventiva S.A. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 112,030 | $648.7K | 0.00% |
| StemPoint Capital LP | 30,824 | $178.5K | 0.04% |
| GWM Advisors LLC | 20,000 | $115.8K | 0.00% |
| AQR Capital Management LLC | 10,000 | $57.9K | 0.00% |
| Rhumbline Advisers | 150 | $868 | 0.00% |
Sold out (2)
Institutions that held Inventiva S.A. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 23,384 | $73.0K |
| BNP Paribas Arbitrage, SA | 100 | $312 |